Idexx Laboratories Q4 FY25: where the revenue came from and where it went
The whole income statement of Idexx Laboratories for this quarter, as one diagram: what earned the revenue, and what it went on.
- Period
- Oct 1 – Dec 31, 2025
- Reported
- Feb 20, 2026
Revenue$1.09B
+14% year over year
Gross profit$0.66B
60% margin
Operating profit$0.32B
29% margin
Net profit$0.25B
23% margin
The numbers
| Item | Value | Share of revenue | Year over year |
|---|---|---|---|
| Revenue | 1.09 | 100% | +14% |
| Veterinary software, services… | 0.35 | 32% | |
| Water segment revenue | 0.20 | 18% | |
| CAG Diagnostics capital… | 0.20 | 18% | +52% |
| CAG Diagnostics services and… | 0.14 | 13% | +5% |
| LPD segment revenue | 0.13 | 12% | |
| Systems and hardware | 0.07 | 6% | +12% |
| Other | 0.01 | 1% | |
| Cost of revenue | −0.43 | 40% | |
| Gross profit | 0.66 | 60% margin | +1pp |
| R&D | −0.07 | 6% | +0pp |
| Sales & marketing | −0.17 | 15% | +0pp |
| G&A | −0.11 | 10% | −1pp |
| Operating profit | 0.32 | 29% margin | +2pp |
| Interest & other costs | −0.01 | ||
| Tax | −0.06 | ||
| Net profit | 0.25 | 23% margin | +0pp |
158 of 418 companies, most recently reported first
New results in your inbox
When a big company reports, we send you a link to its diagram before anyone has time to comment on it. This is a mailing list, not an account: it does not open the diagrams by itself. No spam, one-click unsubscribe.
Drag or use the arrow keys to see the rest